» Articles » PMID: 32918910

Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma

Abstract

Background & Aims: Esophageal adenocarcinoma (EA) and its premalignant lesion, Barrett's esophagus (BE), are characterized by a strong and yet unexplained male predominance (with a male-to-female ratio in EA incidence of up to 6:1). Genome-wide association studies (GWAS) have identified more than 20 susceptibility loci for these conditions. However, potential sex differences in genetic associations with BE/EA remain largely unexplored.

Methods: Given strong genetic overlap, BE and EA cases were combined into a single case group for analysis. These were compared with population-based controls. We performed sex-specific GWAS of BE/EA in 3 separate studies and then used fixed-effects meta-analysis to provide summary estimates for >9 million variants for male and female individuals. A series of downstream analyses were conducted separately in male and female individuals to identify genes associated with BE/EA and the genetic correlations between BE/EA and other traits.

Results: We included 6758 male BE/EA cases, 7489 male controls, 1670 female BE/EA cases, and 6174 female controls. After Bonferroni correction, our meta-analysis of sex-specific GWAS identified 1 variant at chromosome 6q11.1 (rs112894788, KHDRBS2-MTRNR2L9, P = .039) that was statistically significantly associated with BE/EA risk in male individuals only, and 1 variant at chromosome 8p23.1 (rs13259457, PRSS55-RP1L1, P = 0.057) associated, at borderline significance, with BE/EA risk in female individuals only. We also observed strong genetic correlations of BE/EA with gastroesophageal reflux disease in male individuals and obesity in female individuals.

Conclusions: The identified novel sex-specific variants associated with BE/EA could improve the understanding of the genetic architecture of the disease and the reasons for the male predominance.

Citing Articles

Genomics and tumor microenvironment of breast mucoepidermoid carcinoma based on whole-exome and RNA sequencing.

Ge Y, Lin X, He J, Chen W, Lin D, Zheng Y Diagn Pathol. 2024; 19(1):15.

PMID: 38243319 PMC: 10797953. DOI: 10.1186/s13000-024-01439-8.


Proteome Profiling of Brain Vessels in a Mouse Model of Cerebrovascular Pathology.

Haqqani A, Mianoor Z, Star A, Detcheverry F, Delaney C, Stanimirovic D Biology (Basel). 2023; 12(12).

PMID: 38132326 PMC: 10740654. DOI: 10.3390/biology12121500.


Prognosis prediction in esophageal signet-ring-cell carcinoma: a competing risk analysis.

Chen C, Wang Z, Qin Y BMC Gastroenterol. 2023; 23(1):178.

PMID: 37221531 PMC: 10207763. DOI: 10.1186/s12876-023-02818-z.


Alcohol Use and Use Disorder and Cancer Risk: Perspective on Causal Inference.

Zhou H, Vasiliou V Complex Psychiatry. 2023; 8(1-2):9-12.

PMID: 36601413 PMC: 9669948. DOI: 10.1159/000526407.


Today's Mistakes and Tomorrow's Wisdom in Development and Use of Biomarkers for Barrett's Esophagus.

Frei N, Stachler M Visc Med. 2022; 38(3):173-181.

PMID: 35814971 PMC: 9210037. DOI: 10.1159/000521706.


References
1.
Leja J, Essaghir A, Essand M, Wester K, Oberg K, Totterman T . Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. Mod Pathol. 2008; 22(2):261-72. DOI: 10.1038/modpathol.2008.174. View

2.
Dumitrescu L, Barnes L, Thambisetty M, Beecham G, Kunkle B, Bush W . Sex differences in the genetic predictors of Alzheimer's pathology. Brain. 2019; 142(9):2581-2589. PMC: 6736148. DOI: 10.1093/brain/awz206. View

3.
Dong J, Wyss A, Yang J, Price T, Nicolas A, Nalls M . Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans. Mol Neurobiol. 2016; 54(10):8021-8032. PMC: 5441979. DOI: 10.1007/s12035-016-0282-8. View

4.
Gharahkhani P, Fitzgerald R, Vaughan T, Palles C, Gockel I, Tomlinson I . Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Lancet Oncol. 2016; 17(10):1363-1373. PMC: 5052458. DOI: 10.1016/S1470-2045(16)30240-6. View

5.
Shimada K, Ishikawa T, Nakamura F, Shimizu D, Chishima T, Ichikawa Y . Collapsin response mediator protein 2 is involved in regulating breast cancer progression. Breast Cancer. 2013; 21(6):715-23. DOI: 10.1007/s12282-013-0447-5. View